immunologic disorders Flashcards
HAE genetics
AD, C1 inhibitor gene SERPING1 on chromosome 11
rash associated with HAE type 1 and 2
erythema marginatum
HAE with low C4 and low C1INH function and level
type 1
HAE with low C4 and C1INH function with normal to high C1INH level
type 2
decreased in all acute HAE attacks
C2
these complement components are only low in acquired C1-INH deficiency
C1q and C3
how do attenuated androgens help HAE
induce hepatic synthesis of C1 INH
HAE treatment increases PTT
plasma kalikrein ihnhibitors (ecallantide and lanadelumab0
congenital neutropenia AD mutation
elastase
XLA gene
BTK
hyper IgM phenotype with no germinal centers
CD40L deficiency
hyper IgM phenotype with no T cell defect, have germinal centers
AID deficiency
SCID T- B- NK- (3 types)
ADA deficiency (deaf), activated Rac2 defect, reticular dysgenesis
SCID T- B+ NK-
IL2RG gene (yc deficiency) and Jak3 deficiency; note B cells present but not functional
SCID T-B+ NK+
IL7Ralpha, CD3 epsilon (no gamma delta T cells), CD45, coronoin-1A deficiency
T-B- NK+
cernunnos/XLF deficiency (microcephaly, bird like face); Artemis/DCLRE1C deficiency (no microcephaly)
has 13x more ADA than anywhere else in body
thymus
ADA deficiency mechansim
excess dATP inhibits ribonucleotide reducatase
missense mutations in RAG genes, erythroderma (T cells go to skin), FTT, protracted diarrhea, enlargement of spleen liver lymph nodes, Eosinophilia with lack of B cells but enlarged lymph nodes (proliferation of oligoclonal T cells)
Omenn syndrome
STAT3 LOF
Hyper IgE type 1/Job
AD phagocytic cell disorder with increased susceptibility to Mycobacteria, low B, NK and monocytes
GATA2 deficiency
complement deficiency inherited X-linked (rest AD)
properdin deficiency
2 diseases with normal CH50 but absent AH50
properdin deficiency and Factor D deficiency
associated with HSV encephalitis
TLR3 deficiency (TLR3, TRAF3, TRIF, TBK1, UNC93B1)
TLR3,7,8,9 recognize -
viruses
TLR 1, 2, 4, 5, and 6 recognize
extracellular microbial components
mature T cells in absence of costimulation
anergy
T cell suppression mechanism
activated T cells express CTLA-4 and PD-1 after prolonged stimulation
T cells encounter that encounter self-antigen without costimulation, mitochondrial pathway
pro-apoptotic protein Bcl-2-like protein 11 (Bim) pathway, deleted
T cells encounter that encounter self-antigen without costimulation, death receptor pathway
epeated T cell stimulation increases the expression of the death receptor Fas and its ligand ‘Fas-ligand’ on T cells. When adjacent T cells have engagement of Fas to Fas-ligand, apoptotic cell death occur
CTLA4 on activated and regulatory T cells binds
CD80 and 86 B71 and 2 (suppresses further T cell activation)
LFA-1 (CD11a/18) expressed on
leukocytes
selectins expressed on
endothelium
sialyl-LewisX ligands (CD15a) expressed on
leukocytes
integrins
LFA-1 and Mac-1
LAD-1
delayed umbilical cord separation; omphalitis, no pus formation; LFA-1 (CD11a), Mac-1 (CD11b), LOW cd18
LAD-II
no delayed umbilical cord separation; pus impaired but not absent, Bombay (hh) blood group, mutation of FUCT1 (fucosylation), absence of CD15a (sialyl lewis), short stature, developmental delayed, facial dysmorphism
LAD III
delayed umbilical separation, no pus, severe bleeding disorder, NORMAL CD18, CalDAG-GEF-1 mutation
decrease B and NK cells with monocytopenia, susceptibility to mycobacteria
GATA2 deficiency
IgG long half life due to
FcRN (neonatal Fc receptor)
bare lymphocyte syndrome
TAP protein deficiency
receptor and ligand that activate and maintain memory and effector T cells
ICOS and ICOS-ligand
recptor and ligand to activate naive T cells
CD28 on T cells plus B71,2 (CD80,86) on APCs
p-i concept
medication directly interacts with either the major histocompatibility complex (MHC) molecule or the T-cell receptor (TCR) molecule to stimulate an immune response. These hypersensitivity responses are primarily T-cell mediated rather than antibody mediated reactions. In addition, they do not require a sensitization phase and therefore can occur with the first exposure to the drug.
aspirin exacerbated respiratory disease or vancomycin induced “red man syndrome” due to activation of Mas-related G-protein coupled receptor X2 (MTGPRX2) and subsequent mast-cell degranulation.
“pseudo allergic reaction”
FcγRIIIA
expressed on the NK cell which mediates antibody-dependent cell-mediated cytotoxicity
cytokines for class switching to IgE
IL-4 and IL-13 (IL-5 class switch to IgA)
generalized erythroderma, scaly rash, generalized lymphadenopathy, hepatosplenomegaly and chronic diarrhea, increased CD45RO+
Omenn’s syndrome
functionally like Th2 cells but lack T cell antigen receptors. secrete IL-4, IL-5, IL-9, IL-13, and GM-CSF
ILC2 cells
ILC2s express
GATA3
coreceptor is expressed on B cells and facilitates the binding of the B cells to the microbe to enhance B-cell receptor (BCR) signaling that leads to proliferation and differentiation of B cells.
CR2/CD21 recognizes the complement breakdown products of C3b (iC3b, C3d, and C3dg) covalently bonded to the microbial antigen.
B cells engage with microbes through 2 receptors
CR2/CD21 and BCR
During an immune response, eosinophils are recruited to the site of tissue inflammation by
chemokine eotaxin-1 (CCL11) which binds to the chemokine receptor CCR3 expressed on the eosinophils
In T-dependent B-cell activation, which of the following receptor and ligand interactions induces B-cell proliferation and differentiation?
interaction of CD40 expressed on B cells and CD40L expressed on the T cells induces B-cell activation and differentiation
lipid mediators produced by mast cells
PGD2, LTB4,C4,D4,E4
lipid mediators produced by eosinophils
PGE2, LTC4,D4,E4